Business StandardCenter·
Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo
Genentech patent settlement clears legal hurdles for Pebrilzo; competition and pricing will determine commercial gains
Read at Business Standard →
Business · 1 sources covering this
Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo
Genentech patent settlement clears legal hurdles for Pebrilzo; competition and pricing will determine commercial gains
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/b69f6a73dbcba68211cf62a6a0b54eb50070b8e9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo"></iframe>
